We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Discovery Labs Sees Resolution To Manufacturing Issues
Discovery Labs Sees Resolution To Manufacturing Issues
September 4, 2007
Discovery Labs is anticipating approval for its preventative respiratory distress syndrome (RDS) drug Surfaxin in the spring of 2008 as it resolves manufacturing issues that have long-
delayed approval of the product, the company announced last month.